Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Hirohito, Kobayashi"'
Autor:
Hirohito Kobayashi1,2 kobayashi.hirohito@twmu.ac.jp, Kimikazu Yakushijin3, Masahiro Anan4, Kazuhiko Ikeda5, Yoshiki Okuyama6, Shin-ichiro Fujiwara7, Hitoshi Kanno2, Ryuji Tanosaki8, Takayuki Nakayama9, Tokiko Nagamura-Inoue10
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi. 2024, Vol. 70 Issue 1, p12-19. 8p.
Publikováno v:
Tokyo Women's Medical University Journal, Vol 6, Iss 0, Pp 101-107 (2022)
Objective: γδ T cells can recognize and attack cancer cells even in the absence of information from dendritic cells. γδ T cells have been used in immune cell therapy because of their strong ability to kill cancer cells. However, the number of γ
Externí odkaz:
https://doaj.org/article/dece1d6972814ebc9a34e2d013454665
Autor:
Hiroki Ishihara, Yuki Nemoto, Hidekazu Tachibana, Takashi Ikeda, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Publikováno v:
Clinical Genitourinary Cancer; Apr2024, Vol. 22 Issue 2, p549-557.e5, 14p
Autor:
Kuniaki Tanabe, Tomotaka Hattori, Hirohito Kobayashi, Kyoko Koike, Yasuhiro Maki, Takashi Arai, Toshiaki Otsuka, Yasutomo Suzuki, Yukihiro Kondo, Naoki Kawamura
Publikováno v:
Prostate International, Vol 7, Iss 2, Pp 78-81 (2019)
Background: Whether antithrombotic agents should be stopped before prostate biopsy is unsettled. We investigated the impact of antithrombotic agents on bleeding complications after prostate biopsy. Materials and methods: Among the patients who underw
Externí odkaz:
https://doaj.org/article/b19c028d63324993a8d3f227be7cabfa
Autor:
Hiroki Ishihara, Yuki Nemoto, Kazutaka Nakamura, Hidekazu Tachibana, Takashi Ikeda, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Publikováno v:
Targeted Oncology. 18:209-220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55c43b9a01a722131bccd00a9df039df
https://doi.org/10.1007/s11523-023-00956-8
https://doi.org/10.1007/s11523-023-00956-8
Autor:
Hiroki Ishihara, Yudai Ishiyama, Yuki Nemoto, Kazutaka Nakamura, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Kazunari Tanabe, Tsunenori Kondo, Toshio Takagi
Publikováno v:
Clinical Genitourinary Cancer. 21:136-145
To clarify the impact of body mass index (BMI) on treatment outcomes including survival, tumor response, and adverse events (AEs) in patients with advanced renal cell carcinoma (RCC) or urothelial carcinoma (UC) treated with immune checkpoint inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603e3bbff6b778b5458ff85c20528baf
https://doi.org/10.1016/j.clgc.2022.08.001
https://doi.org/10.1016/j.clgc.2022.08.001
Autor:
Junji Tanaka, Norina Tanaka, Yan-Hua Wang, Kenjiro Mitsuhashi, Michiko Ryuzaki, Yuki Iizuka, Aya Watanabe, Midori Ishiyama, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Yumi Kougen, Hirohito Kobayashi, Hitoshi Kanno, Masayuki Shiseki
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/217b9b5923bc4608a54b1490e400b057
Autor:
Hiroki Ishihara, Yuki Nemoto, kazutaka Nakamura, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Publikováno v:
Journal of Urology. 209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1193638f0836ba0cc8c155ad22c3d493
https://doi.org/10.1097/ju.0000000000003256.08
https://doi.org/10.1097/ju.0000000000003256.08
Autor:
Hiroki Ishihara, Yuki Nemoto, Kazutaka Nakamura, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Publikováno v:
Journal of Urology. 209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ec2de9c455bb7cc00d8d7a1bfc37283
https://doi.org/10.1097/ju.0000000000003256.10
https://doi.org/10.1097/ju.0000000000003256.10
Autor:
Hiroki Ishihara, Yuki Nemoto, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Yasunobu Hashimoto, Toshio Takagi, Hideki Ishida, Tsunenori Kondo, Kazunari Tanabe
Publikováno v:
Japanese Journal of Clinical Oncology. 52:785-790
Objectives To investigate the long-term follow-up outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma, using real-world data. Methods A total of 121 patients were treated with nivolumab monotherapy as subsequent t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0ae875ee51814cc8f7d11bc6d21bbae
https://doi.org/10.1093/jjco/hyac044
https://doi.org/10.1093/jjco/hyac044